all report title image
  • Published In : Nov 2023
  • Code : CMI5909
  • Pages : 160
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Fanconi Anemia Drug, By Treatment Type
      • Market Fanconi Anemia Drug, By Age Group
      • Market Fanconi Anemia Drug, By Disease Stage
      • Market Fanconi Anemia Drug, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Continuous advancements in scientific research and understanding of the molecular mechanisms
        • Substantial unmet medical need
      • Restraints
        • Lack of recognized therapies
      • Opportunities
        • Development of Disease-Modifying Therapies
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Fanconi Anemia Drug Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Global Fanconi Anemia Drug Market, By Treatment Type, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019–2030
      • Segment Trends
    • Hematopoietic Growth Factors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Gene Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Stem Cell Transplantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Other Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  6. Global Fanconi Anemia Drug Market, By Age Group, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019–2030
      • Segment Trends
    • Pediatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    •  Adult Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  7. Global Fanconi Anemia Drug Market, By Disease Stage, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019–2030
      • Segment Trends
    • Early-stage Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
    • Advanced-stage Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  8. Global Fanconi Anemia Drug Market, By Region, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Region, 2018 –2030
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape
    • Foresee Pharmaceuticals Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Rocket Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Amgen
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Gilead Sciences, Inc. (Kite Pharma, Inc.)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Celgene Corporation (Juno Therapeutics)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Spark Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • UniQure N.V
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bluebird Bio, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • PTC Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Orchard Therapeutics Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GlaxoSmithKline Plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Aurora Biopharma, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Autolus Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  10. Section
    • Research Methodology
    • About us

*Browse 35 market data tables and 30 figures on “Global Fanconi Anemia Drug Market” - Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo